Abstract
We describe two cases of leflunomide-related interstitial pneumonia (IP). A 75-year-old woman with rheumatoid arthritis (RA) developed rapidly progressing IP 45 days after institution of leflunomide. She died of respiratory failure, and an autopsy revealed a mixed pattern of acute and organizing diffuse alveolar damage. A 69-year-old woman with RA also developed acute IP 3 months after institution of leflunomide. Methylprednisolone pulse therapy and cholestyramine ameliorated her IP. The implication of leflunomide in the pathogenesis of IP was suggested.
MeSH terms
-
Aged
-
Anti-Inflammatory Agents / therapeutic use
-
Antirheumatic Agents / adverse effects*
-
Arthritis, Rheumatoid / drug therapy*
-
Autopsy
-
Cholestyramine Resin / therapeutic use
-
Female
-
Humans
-
Isoxazoles / adverse effects*
-
Leflunomide
-
Lung Diseases, Interstitial / chemically induced*
-
Lung Diseases, Interstitial / pathology*
-
Lung Diseases, Interstitial / physiopathology
-
Methylprednisolone / therapeutic use
-
Pulmonary Alveoli / diagnostic imaging
-
Pulmonary Alveoli / pathology
-
Tomography, X-Ray Computed
Substances
-
Anti-Inflammatory Agents
-
Antirheumatic Agents
-
Isoxazoles
-
Cholestyramine Resin
-
Leflunomide
-
Methylprednisolone